(Reuters) - Earnings before interest and taxes from continuing operations, excluding Organon BioSciences and one-off items, rose to 279 million euros in the second quarter compared with a year earlier, above an average forecast of 255 million euros in a Reuters poll of 13 analysts.
Akzo Nobel shares rose 1.3 percent to 63.75 euros by 1035 GMT, outperforming a 0.6 percent fall in the DJ Stoxx European chemical index .
Read more at Reuters.com Mergers News
Akzo Nobel shares rose 1.3 percent to 63.75 euros by 1035 GMT, outperforming a 0.6 percent fall in the DJ Stoxx European chemical index .
Read more at Reuters.com Mergers News
No comments:
Post a Comment